Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on August 9, 2025

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed

Zacks

a month ago

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy

Zacks

a month ago

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy

Scoop Up These 4 GARP Stocks to Receive Handsome Returns

Zacks

a month ago

Scoop Up These 4 GARP Stocks to Receive Handsome Returns

Argus Research

2 months ago

RMD: Raising target price to $269.00

Morningstar Research

2 months ago

Analyst Report: ResMed Inc.

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

StockStory

2 months ago

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

Argus Research

2 months ago

RMD: Raising target price to $265.00

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks

2 months ago

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

StockStory

2 months ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Zacks

2 months ago

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

StockStory

2 months ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

StockStory

2 months ago

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

Newsfile

2 months ago

Sienna Resources Inc. Announces Private Placement

Energy Global

2 months ago

European Energy completes sale of Polish wind portfolio to Enea Group

Newsfile

2 months ago

Carbone Restaurant Group is a GOLD Sponsor at the Centurion One Capital 6th Annual LA Summit

Newsfile

2 months ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Yahoo Personal Finance

2 months ago

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Investing.com

2 months ago

Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

Report: Slower economy doesn't dim downtown Austin's dynamism

Austin American-Statesman

2 months ago

Report: Slower economy doesn't dim downtown Austin's dynamism

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

GuruFocus.com

2 months ago

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Zacks

3 months ago

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Zacks

3 months ago

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

1 Surging Stock with Exciting Potential and 2 to Avoid

StockStory

3 months ago

1 Surging Stock with Exciting Potential and 2 to Avoid

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

TipRanks

3 months ago

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

StockStory

3 months ago

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

3 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Motley Fool

3 months ago

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

GlobeNewswire

3 months ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

StockStory

3 months ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

Argus Research

3 months ago

RMD: Rating increased to a BUY

Argus Research

3 months ago

RMD: Raising target price to $254.00

3 Profitable Stocks to Consider Right Now

StockStory

3 months ago

3 Profitable Stocks to Consider Right Now

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

Simply Wall St.

3 months ago

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

This ResMed Insider Reduced Their Stake By 72%

Simply Wall St.

3 months ago

This ResMed Insider Reduced Their Stake By 72%

Resmed acquires independent diagnostic testing facility VirtuOx

Medical Device Network

3 months ago

Resmed acquires independent diagnostic testing facility VirtuOx

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MedTech Dive

3 months ago

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MT Newswires

3 months ago

ResMed Buys VirtuOx for Undisclosed sum

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

3 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Resmed Acquires VirtuOx

GlobeNewswire

3 months ago

Resmed Acquires VirtuOx

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

Insider Monkey

3 months ago

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

iRhythm Earnings: What To Look For From IRTC

StockStory

3 months ago

iRhythm Earnings: What To Look For From IRTC

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

StockStory

3 months ago

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

Zacks

3 months ago

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

3 months ago

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

Simply Wall St.

4 months ago

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

MT Newswires

4 months ago

KeyBanc Adjusts Price Target on ResMed to $274 From $269, Maintains Overweight Rating

MT Newswires

4 months ago

Jefferies Adjusts Price Target on ResMed to $245 From $270, Maintains Hold Rating

MT Newswires

4 months ago

Piper Sandler Adjusts Price Target on ResMed to $248 From $260, Maintains Neutral Rating

MT Newswires

4 months ago

Morgan Stanley Adjusts Price Target on ResMed to $286 From $280, Maintains Overweight Rating

MT Newswires

4 months ago

JPMorgan Adjusts Price Target on ResMed to $290 From $286, Maintains Overweight Rating

MT Newswires

4 months ago

Mizuho Adjusts Price Target on ResMed to $250 From $265, Maintains Outperform Rating

MT Newswires

4 months ago

Wolfe Research Adjusts Price Target on ResMed to $200 From $195, Maintains Underperform Rating

Thomson Reuters StreetEvents

4 months ago

Q3 2025 Resmed Inc Earnings Call

Morningstar Research

4 months ago

Analyst Report: ResMed Inc.

MT Newswires

4 months ago

RBC Raises Price Target on ResMed to $255 From $247, Keeps Sector Perform Rating

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

Zacks

4 months ago

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

4 months ago

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

Zacks

4 months ago

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

Zacks

4 months ago

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

StockStory

4 months ago

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

StockStory

4 months ago

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

Resmed Names Salli Schwartz as Chief Investor Relations Officer

GlobeNewswire

4 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

Zacks

4 months ago

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

MT Newswires

4 months ago

KeyBanc Adjusts ResMed Price Target to $269 From $280, Maintains Overweight Rating

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

Zacks

4 months ago

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

4 months ago

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

MT Newswires

4 months ago

Mizuho Securities Adjusts ResMed Price Target to $265 From $280, Maintains Outperform Rating

Argus Research

4 months ago

RMD: Rating decreased to a HOLD

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

4 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

MT Newswires

4 months ago

Baird Cuts Price Target on ResMed to $252 From $286, Maintains Outperform Rating

MT Newswires

4 months ago

ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says

Morningstar Research

4 months ago

Analyst Report: ResMed Inc.

Argus Research

4 months ago

RMD: Lowering target price to $241.00

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Zacks

4 months ago

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

4 months ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

Simply Wall St.

4 months ago

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

ResMed Inc. (RMD): A Bull Case Theory

Insider Monkey

4 months ago

ResMed Inc. (RMD): A Bull Case Theory

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

GlobeNewswire

4 months ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Insider Monkey

4 months ago

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

GlobeNewswire

4 months ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Argus Research

4 months ago

RMD: Rating increased to a BUY

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

TipRanks

4 months ago

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Insider Monkey

4 months ago

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Argus Research

4 months ago

RMD: Raising target price to $232.00

ResMed initiated with an Overweight at Morgan Stanley

TipRanks

5 months ago

ResMed initiated with an Overweight at Morgan Stanley

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

GlobeNewswire

5 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

New Product Launches Benefit GMED Stock Amid Macro Issues

Zacks

5 months ago

New Product Launches Benefit GMED Stock Amid Macro Issues

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

5 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

Zacks

5 months ago

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

5 months ago

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

5 months ago

RMD Stock Likely to Benefit From the New Brand Evolution Strategy

MT Newswires

5 months ago

Resmed Consolidating Brands, Product Lines Under Single Name

GlobeNewswire

5 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

StockStory

5 months ago

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

Investor's Business Daily

5 months ago

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

VEEV Stock Gains Following Latest Availability of HCP Access Data

Zacks

5 months ago

VEEV Stock Gains Following Latest Availability of HCP Access Data

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks

5 months ago

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

Zacks

5 months ago

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

Zacks

5 months ago

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

Zacks

5 months ago

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

Share on Social Networks: